Sign in
4

Changes in Ownership

InMed Pharmaceuticals Inc. Filed Acc 0001213900-22-080959

Options or other derivatives

  • Director acquired 840 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HULL ANDREW Director 2022-12-16 Grant or award · Employee Stock Option (Right to Buy) +840 1,484 D
Loading xslF345X03/ownership.xml…